Authrs and Affiliations:
Sofia Braga, Joana Cardoso, Saudade André, Margarida Brito, Pedro Sanchez, Lurdes Orvalho, Lucília Salgado, Sérgio Dias, José B. Pereira-Leal and José Luís Passos-Coelho
Jose de Mello Saude, Lisboa, Portugal.
Abstract:
Background: The antiangiogenic drug sunitinib has never been evaluated as single agent in untreated breast cancer patients.